2 days Ago Marvel Biosciences ( TSXV: MRVL:CA ) and its wholly owned subsidiary, Marvel Biotechnology, said on Friday that it has closed the first tranche of a non-brokered private placement of up to 12M units at a price of $0.125 per unit for gross.
